MedPath

UCB PHARMA (HONG KONG) LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

PPB:21

Drug Approvals

BIMZELX SOLUTION FOR INJECTION IN PRE-FILLED PEN 160MG/ML

Approval Date
Feb 19, 2025
PPB

BIMZELX SOLUTION FOR INJECTION IN PRE-FILLED PEN 160MG/ML

Approval Date
Feb 19, 2025
PPB

♇ FINTEPLA ORAL SOLUTION 2.2MG/ML

Approval Date
Dec 16, 2024
PPB

CIMZIA SOLUTION FOR INJECTION IN PRE-FILLED PENS 200MG/1ML

Approval Date
Nov 10, 2021
PPB

BRIVIACT ORAL SOLUTION 10MG/ML

Approval Date
Oct 22, 2018
PPB

BRIVIACT SOLUTION FOR INJECTION/INFUSION 50MG/5ML

Approval Date
Oct 22, 2018
PPB

BRIVIACT TABLETS 50MG

Approval Date
Oct 22, 2018
PPB

BRIVIACT TABLETS 100MG

Approval Date
Oct 22, 2018
PPB

BRIVIACT TABLETS 25MG

Approval Date
Oct 22, 2018
PPB

BRIVIACT TABLETS 10MG

Approval Date
Oct 22, 2018
PPB
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.